Regulatory Exclusivity Periods. With respect to any Patent listings required for any Regulatory Exclusivity Periods for Product, the Parties will mutually agree on which Patents within the Licensed IP to list, provided that if the Parties are not able to agree, Celgene will have the right to make the final decision, and provided further that the exercise of such right by Celgene will not increase or otherwise change the rights or obligations of the Parties hereunder.
Appears in 14 contracts
Samples: License Agreement (2seventy Bio, Inc.), License Agreement (2seventy Bio, Inc.), Co Development, Co Promote and Profit Share Agreement (2seventy Bio, Inc.)
